SERUM TRANSAMINASE TESTS FOR LIVER FUNCTION ON OUTPATIENTS IN FOLLOW-UP CLINIC
Abstract
The dosage of ataraxics which these patients were receiving was considered to be their maintenance dosage and the smallest amount of treatment necessary, which may be the reason for the negative reports of liver damage. The effect of the medication on the individual patient, not the medicine or chemicals themselves, must be the primary consideration in all treatments(4). It is felt that the medication has kept these patients out of hospitals and helped them in adjusting for prolonged periods without the risk of harmful effects on the liver, even though they are not cured of their original mental illnesses(5).
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
